Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

"PTCH"-ing it together: a basal cell nevus syndrome review.

Lam C, Ou JC, Billingsley EM.

Dermatol Surg. 2013 Nov;39(11):1557-72. doi: 10.1111/dsu.12241. Epub 2013 May 31.

PMID:
23725561
2.

Basal cell nevus syndrome: clinical and molecular review and case report.

Pino LC, Balassiano LK, Sessim M, de Almeida AP, Empinotti VD, Semenovitch I, Treu C, Lupi O.

Int J Dermatol. 2016 Apr;55(4):367-75. doi: 10.1111/ijd.12993. Epub 2015 Sep 10. Review.

PMID:
26356331
3.

Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.

Zedan W, Robinson PA, Markham AF, High AS.

J Pathol. 2001 Aug;194(4):473-7.

PMID:
11523056
4.

Gorlin syndrome or basal cell nevus syndrome (BCNS): A case report.

Shivaswamy KN, Sumathy TK, Shyamprasad AL, Ranganathan C.

Dermatol Online J. 2010 Sep 15;16(9):6.

5.

[From gene to disease: basal cell naevus syndrome].

de Meij TG, Baars MJ, Gille JJ, Hack WW, Haasnoot K, van Hagen JM.

Ned Tijdschr Geneeskd. 2005 Jan 8;149(2):78-81. Review. Dutch.

PMID:
15688838
6.

Treatment of multiple unresectable basal cell carcinomas from Gorlin-Goltz syndrome: a case report.

Ojevwe FO, Ojevwe CD, Zacny JP, Dudek AZ, Lin A, Kohlitz P.

Anticancer Res. 2015 Mar;35(3):1777-81.

PMID:
25750342
7.

Resolution of odontogenic keratocysts of the jaw in basal cell nevus syndrome with GDC-0449.

Goldberg LH, Landau JM, Moody MN, Kazakevich N, Holzer AM, Myers A.

Arch Dermatol. 2011 Jul;147(7):839-41. doi: 10.1001/archdermatol.2011.50. Epub 2011 Mar 21.

PMID:
21422324
8.

Ingenol Mebutate Treatment in a Patient with Gorlin Syndrome.

Stieger M, Hunger RE.

Dermatology. 2016;232 Suppl 1:29-31. doi: 10.1159/000447394. Epub 2016 Aug 11.

9.

Features of basal cell carcinomas in basal cell nevus syndrome.

Tom WL, Hurley MY, Oliver DS, Shah MR, Bree AF.

Am J Med Genet A. 2011 Sep;155A(9):2098-104. doi: 10.1002/ajmg.a.34127. Epub 2011 Aug 10.

PMID:
21834051
10.

Basal cell nevus syndrome: clinical and genetic diagnosis.

García de Marcos JA, Dean-Ferrer A, Arroyo Rodríguez S, Calderón-Polanco J, Alamillos Granados FJ, Poblet E.

Oral Maxillofac Surg. 2009 Dec;13(4):225-30. doi: 10.1007/s10006-009-0169-1.

PMID:
19795138
11.

Germline PTCH1 mutations in Japanese basal cell nevus syndrome patients.

Takahashi C, Kanazawa N, Yoshikawa Y, Yoshikawa R, Saitoh Y, Chiyo H, Tanizawa T, Hashimoto-Tamaoki T, Nakano Y.

J Hum Genet. 2009 Jul;54(7):403-8. doi: 10.1038/jhg.2009.55. Epub 2009 Jun 26.

PMID:
19557015
12.

Basal cell nevus syndrome or Gorlin syndrome.

Thalakoti S, Geller T.

Handb Clin Neurol. 2015;132:119-28. doi: 10.1016/B978-0-444-62702-5.00008-1. Review.

PMID:
26564075
13.

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.

Chang AL, Solomon JA, Hainsworth JD, Goldberg L, McKenna E, Day BM, Chen DM, Weiss GJ.

J Am Acad Dermatol. 2014 Jan;70(1):60-9. doi: 10.1016/j.jaad.2013.09.012. Epub 2013 Nov 1.

14.

Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.

Rodrigues AL, Carvalho A, Cabral R, Carneiro V, Gilardi P, Duarte CP, Puente-Prieto J, Santos P, Mota-Vieira L.

Genet Mol Res. 2014 Jul 25;13(3):5654-63. doi: 10.4238/2014.July.25.21.

15.

Manifestations of Gorlin-Goltz syndrome.

Larsen AK, Mikkelsen DB, Hertz JM, Bygum A.

Dan Med J. 2014 May;61(5):A4829.

PMID:
24814739
16.

Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Lo Muzio L.

Orphanet J Rare Dis. 2008 Nov 25;3:32. doi: 10.1186/1750-1172-3-32. Review.

17.

Basal cell nevus syndrome showing several histologic types of Basal cell carcinoma.

Go JW, Kim SH, Yi SY, Cho HK.

Ann Dermatol. 2011 Sep;23 Suppl 1:S36-40. doi: 10.5021/ad.2011.23.S1.S36. Epub 2011 Sep 30. Retraction in: Bang D. Ann Dermatol. 2012 May;24(2):242.

18.

PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.

Santos DC, Zaphiropoulos PG, Neto CF, Pimentel ER, Sanches JA Jr, Ruiz IR.

Int J Dermatol. 2011 Jul;50(7):838-43. doi: 10.1111/j.1365-4632.2010.04866.x.

PMID:
21699520
19.

Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.

Tang JY.

Semin Cutan Med Surg. 2011 Dec;30(4 Suppl):S6-9. doi: 10.1016/j.sder.2011.11.001. Review.

PMID:
22177103
20.

Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.

Dessinioti C, Plaka M, Stratigos AJ.

Future Oncol. 2014 May;10(6):927-36. doi: 10.2217/fon.14.50.

PMID:
24941979

Supplemental Content

Support Center